I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bajorin, D.F
255
results:
Search for persons
X
Format
Online (255)
Mediatypes
Articles (Online) (125)
Bookchapter (Online) (2)
OpenAccess-fulltext (128)
Sorted by: Relevance
Sorted by: Year
?
1
Tumor and immune features associated with disease-free surv..:
Necchi, A.
;
Bajorin, D.F.
;
Tomita, Y.
...
European Urology Open Science. 45 (2022) - p. S239-S240 , 2022
Link:
https://doi.org/10.1016/..
?
2
Updated follow-up from KEYNOTE-057: Phase 2 study of pembro..:
Boormans, J.L.
;
De Wit, R.
;
Kulkarni, G.S.
...
European Urology Open Science. 19 (2020) - p. e1173-e1174 , 2020
Link:
https://doi.org/10.1016/..
?
3
Randomized phase III KEYNOTE-045 trial of pembrolizumab ver..:
Fradet, Y.
;
Bellmunt, J.
;
Vaughn, D.J.
...
Annals of Oncology. 30 (2019) 6 - p. 970-976 , 2019
Link:
https://doi.org/10.1093/..
?
4
Activity of the FGFR1–3 inhibitor infigratinib in patients ..:
De Giorgi, U.
;
Pal, S.K.
;
Rosenberg, J.E.
...
European Urology Supplements. 18 (2019) 11 - p. e3405-e3406 , 2019
Link:
https://doi.org/10.1016/..
?
5
Impact of the Number of Prior Lines of Therapy and Prior Pe..:
Pond, G.R.
;
Bellmunt, J.
;
Rosenberg, J.E.
...
Clinical Genitourinary Cancer. 13 (2015) 1 - p. 71-79 , 2015
Link:
https://doi.org/10.1016/..
?
6
Somatic ERCC2 Mutations Confer Cisplatin Sensitivity in Mus..:
Mouw, K.
;
Van Allen, E.
;
O'Connor, K.
...
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 1 - p. S88 , 2014
Link:
https://doi.org/10.1016/..
?
7
Image-Guided Intensity Modulated Radiation Therapy (IMRT) f..:
Kollmeier, M.A.
;
Thakker, N.
;
Zelefsky, M.J.
...
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 1 - p. S463 , 2014
Link:
https://doi.org/10.1016/..
?
8
Impact of the number of lymph nodes retrieved on outcome in..:
Herr, H.W
;
Bochner, B.H
;
Dalbagni, G
...
Urologic Oncology: Seminars and Original Investigations. 21 (2003) 2 - p. 168-169 , 2003
Link:
https://doi.org/10.1016/..
?
9
Exploring sequenced chemotherapy regimens in the treatment ..:
Bajorin, D.F
European Journal of Cancer. 36 (2000) - p. 26-29 , 2000
Link:
https://doi.org/10.1016/..
?
10
Acute Nonlymphocytic Leukemia in Germ Cell Tumor Patients T..:
Bajorin, D. F.
;
Motzer, R. J.
;
Rodriguez, E.
..
JNCI Journal of the National Cancer Institute. 85 (1993) 1 - p. 60-62 , 1993
Link:
https://doi.org/10.1093/..
?
11
Phase II Trial of High-Dose Carboplatin and Etoposide With ..:
Motzer, R. J.
;
Mazumdar, M.
;
Gulati, S. C.
...
JNCI Journal of the National Cancer Institute. 85 (1993) 22 - p. 1828-1835 , 1993
Link:
https://doi.org/10.1093/..
?
12
Treatment with high dose mouse monoclonal (anti-GD3) antibo..:
Bajorin, D. F.
;
Chapman, P. B.
;
Wong, G. Y.
...
Melanoma Research. 2 (1992) 5 - p. 355-362 , 1992
Link:
https://doi.org/10.1097/..
?
13
BOOK REVIEWS:
BAJORIN, D. F.
JNCI Journal of the National Cancer Institute. 80 (1988) 2 - p. 136-136 , 1988
Link:
https://doi.org/10.1093/..
?
14
Corrigendum to "Disease-free Survival Analysis for Patients..:
Galsky, Matthew D.
;
Bajorin, Dean F.
;
Witjes, Johannes Alfred
...
European Urology. 85 (2024) 3 - p. e96-e97 , 2024
Link:
https://doi.org/10.1016/..
?
15
Pembrolizumab monotherapy for high-risk non-muscle-invasive..:
Necchi, Andrea
;
Roumiguié, Mathieu
;
Kamat, Ashish M
...
The Lancet Oncology. 25 (2024) 6 - p. 720-730 , 2024
Link:
https://doi.org/10.1016/..
1-15